INTS Stock Analysis: Buy, Sell, or Hold?
INTS - Intensity Therapeutics, Inc. Common stock
$4.26
0.11 (2.65%)
▲
5d:
-6.78%
30d:
+0.47%
90d:
-17.92%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Get Alerted When INTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INTS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INTS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INTS is currently trading at $4.26, which is considered slightly low relative to its 30-day fair value range of $4.20 to $4.80.
Technical Outlook: Technically, INTS is in a downtrend. Immediate support is located at $4.01, while resistance sits at $4.75.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.80 (+482.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INTS is in a downtrend. Immediate support is located at $4.01, while resistance sits at $4.75.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.80 (+482.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.20 -
$4.80
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 482.2% below Wall St target ($24.80)
- CAUTION: Recommendation downgraded due to -6.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.20 -
$4.80
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.01
Resistance Level
$4.75
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.58
Wall Street Target
$24.80
(+482.2%)
Share & Embed Analysis
Last updated: August 04, 2026 12:28 AM ET
Data refreshes hourly during market hours. Next update: 1:28 AM
Data refreshes hourly during market hours. Next update: 1:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
